The Growth Dilemma: To Float or To Sell? (FILM)


The IPO process of buying and selling is the subject of this Criticaleye breakfast Forum held in association with Cass Business School. Featuring speeches from Cass' Robert Cressy, LongAcre Partners Julian Culhane and Library House Founder and Chairman, Doug Richard, topics of discussion include:

• what makes a suitable buyer in acquisitions and trade sales
• the role of private equity
• retaining leaders in listed companies
• extracting value from the IPO process

Share this with your Community


Contributors
Doug Richard
Founder
School for Startups
Julian Culhane
FORMER Managing Director - Head of European Media Investment Banking
Jefferies Group
Robert Cressy
Professor of Finance
Cass Business School


Click here to download this insight

DOWNLOAD INSIGHT



Related Insights

Read, watch & listen to some of the latest thought leadership from our Community.

Click here to download this insight
2026 Enterprise Software Tech...

In this report, Criticaleye Partner AlixPartners suggest that 2026 will likely mark a structural turning point for enterprise software, as AI reshapes not only how software is built, but how it is priced,...

Click here to download this insight
Shaping the Future of AIM

This Discussion Paper Feedback Statement by Criticaleye's Advisory Member London Stock Exchange Group has been published following a recent call for input from all stakeholders relating to the future of Lo...

Click here to download this insight
Inside the Take-private at Pr...

After a whirlwind journey from the NYSE to private ownership, PropertyGuru CFO Joe Dische reflects on making the hard calls. In this interview with Criticaleye Senior Editor Bridgette Hall, he discusses public vs privat...


1 2 3 4 5 6 7 8 9 10
Displaying 1 to 3 of 277




Aldermore Group AlixPartners Lightsource bp Eightfold AI London Stock Exchange Group FTSE Women Leaders Review NatWest Group IBM Consulting NATS British Land Salesforce Workday Legal & General Worldpay Rolls-Royce E.ON UK Accenture GlaxoSmithKline plc Drax Group plc Hitachi Solutions Concentrix Google Palo Alto Networks